Your browser doesn't support javascript.
loading
Impact of SCHOLAR-1 Criteria on Chimeric Antigen Receptor T Cell Therapy Efficacy in Aggressive B Lymphoma: A Real-World GELTAMO/GETH Study.
Bastos-Oreiro, Mariana; Gutierrez, Antonio; Iacoboni, Gloria; López Corral, Lucía; Reguera, Juan Luis; Abrisqueta, Pau; Delgado, Javier; Terol, María José; Hernani, Rafael; Martínez, Nuria; Ortíz, Valentín; Bailen, Rebeca; Gomez-Centurión, Ignacio; Caballero, Ana; Sanz, Jaime; Guerra Domínguez, Luisa; Luzardo, Hugo; Mussetti, Alberto; Jiménez-Ubieto, Ana; Sancho, Juan Manuel; Sureda, Anna; Pérez, Antonio; Barba, Pere; Kwon, Mi; Martín García-Sancho, Alejandro.
Affiliation
  • Bastos-Oreiro M; Hospital Universitario Gregorio Maran, Instituto de investigación sanitaria Gregorio Marañon (IisGM), Madrid, Spain. Electronic address: marianabeatriz.bastos@salud.madrid.org.
  • Gutierrez A; Hospital Universitario Son Espases, IdISBa, Palma de Mallorca, Spain.
  • Iacoboni G; Hospital Universitario Vall d´Hebron, Barcelona, Spain.
  • López Corral L; Hospital Clínico Universitario de Salamanca, IBSAL, CIBERONC, Salamanca, Spain.
  • Reguera JL; Hospital Universitario Virgen del Rocío, Sevilla, Spain.
  • Abrisqueta P; Hospital Universitario Vall d´Hebron, Barcelona, Spain.
  • Delgado J; Hospital Universitario Virgen del Rocío, Sevilla, Spain.
  • Terol MJ; Hospital Clínico Universitario de Valencia, Valencia, Spain.
  • Hernani R; Hospital Clínico Universitario de Valencia, Valencia, Spain.
  • Martínez N; Hospital Clínic de Barcelona, Barcelona, Spain.
  • Ortíz V; Hospital Clínic de Barcelona, Barcelona, Spain.
  • Bailen R; Hospital Universitario Gregorio Maran, Instituto de investigación sanitaria Gregorio Marañon (IisGM), Madrid, Spain.
  • Gomez-Centurión I; Hospital Universitario Gregorio Maran, Instituto de investigación sanitaria Gregorio Marañon (IisGM), Madrid, Spain.
  • Caballero A; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Sanz J; Hospital Universitario La Fé de Valencia, Balencia, Spain.
  • Guerra Domínguez L; Hospital Universitario Dr. Negrin, Las Palmas de Gran Canaria, Spain.
  • Luzardo H; Hospital Universitario Dr. Negrin, Las Palmas de Gran Canaria, Spain.
  • Mussetti A; Institut Català d'Oncologia-Hospitalet, IDIBELL, Universitat de Barcelona, Barcelona, Spain.
  • Jiménez-Ubieto A; Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Sancho JM; Hospital ICO- Hospital Germans Trias y Pujol, Badalona, Spain.
  • Sureda A; Institut Català d'Oncologia-Hospitalet, IDIBELL, Universitat de Barcelona, Barcelona, Spain.
  • Pérez A; Hospital Universitario La Paz, Madrid, Spain.
  • Barba P; Hospital Universitario Vall d´Hebron, Barcelona, Spain.
  • Kwon M; Hospital Universitario Gregorio Maran, Instituto de investigación sanitaria Gregorio Marañon (IisGM), Madrid, Spain.
  • Martín García-Sancho A; Hospital Clínico Universitario de Salamanca, IBSAL, CIBERONC, Salamanca, Spain.
Transplant Cell Ther ; 29(12): 747.e1-747.e10, 2023 Dec.
Article in En | MEDLINE | ID: mdl-37659694

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, B-Cell / Hematopoietic Stem Cell Transplantation / Receptors, Chimeric Antigen / Lymphoma Type of study: Clinical_trials / Observational_studies / Prognostic_studies Limits: Adult / Humans Language: En Journal: Transplant Cell Ther Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, B-Cell / Hematopoietic Stem Cell Transplantation / Receptors, Chimeric Antigen / Lymphoma Type of study: Clinical_trials / Observational_studies / Prognostic_studies Limits: Adult / Humans Language: En Journal: Transplant Cell Ther Year: 2023 Document type: Article